Expression of ERCC1 and TYMS in colorectal cancer patients and the predictive value of chemotherapy efficacy

The present study investigated the expression of excision repair cross-complementing gene 1 (ERCC1) and thymidylate synthase (TYMS) in patients with colorectal cancer and the predictive value of chemotherapy. Eighty patients with colorectal cancer chemotherapy admitted to Binzhou Medical University...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hong, Li, Baosong, Wang, Fengxia, Ma, Chong, Hao, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607089/
https://www.ncbi.nlm.nih.gov/pubmed/31423175
http://dx.doi.org/10.3892/ol.2019.10395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607089/
https://www.ncbi.nlm.nih.gov/pubmed/31423175
http://dx.doi.org/10.3892/ol.2019.10395

Ejemplares similares